MINI REVIEW article

Front. Cell Dev. Biol., 03 September 2025

Sec. Membrane Traffic and Organelle Dynamics

Volume 13 - 2025 | https://doi.org/10.3389/fcell.2025.1593840

Specialised features of melanosomes in health and disease in the retinal pigment epithelium

  • UCL Institute of Ophthalmology, University College London, London, United Kingdom

Abstract

This mini-review focuses on melanosome biogenesis, positioning and function in the retinal pigment epithelium (RPE) where melanosomes absorb light scatter and protect against the harmful effects of photo-oxidation. RPE melanosomes share a common biogenesis pathway with those of skin melanocytes but are made primarily embryonically and are retained by the RPE throughout life. They do however move from the cell body into the apical processes which, in mammalian RPE, is regulated by a machinery related to that regulating melanosome distribution in skin melanocytes. Melanosomes in the RPE make extensive membrane contacts with the ER and mitochondria although their role in adult RPE remains to be fully established. Albinism is associated with multiple visual defects and reduced or absent pigmentation in melanosomes has implications for long term visual health. Age-related changes in melanosomes have been implicated in retinal degenerative disease, including age-related macular disease (AMD). The lysosomes of the RPE have an unparalleled degradative burden arising from the daily phagocytosis of the distal tips of photoreceptor outer segments, which is part of a daily process of outer segment renewal. A failure to fully process the phagocytosed outer segments leads to a build-up of the toxic ageing pigment, lipofuscin, which accumulates in all ageing RPE. Melanolipofuscin also accumulates in the RPE with age and may result from melanin-mediated degradation of lipofuscin through melanin chemiexcitation. Age-related loss of melanosome-mediated protection could be an important component of age-related visual decline.

1 Introduction

The retinal pigment epithelium (RPE) forms a monolayer of highly pigmented postmitotic cells at the back of the eye that is central to photoreceptor health, retinal homeostasis and normal visual function. RPE cells are polarised, interfacing apically with the neuroretina and basally with the highly vascularised choroid via a connective tissue layer called Bruch’s membrane (Figure 1A). Thus, the RPE forms part of the blood retinal barrier and regulates transport between the neuroretina and choroidal blood supply. Apically positioned tight junctions help maintain the integrity of the monolayer and enable the RPE to regulate transport between the choroidal blood supply and the neuroretina.

FIGURE 1

Light-sensing photoreceptors are subject to damage and require continuous renewal of their outer segments (OS) to maintain viability. In humans, OS undergo complete renewal approximately every 11 days, with the damaged OS tips being phagocytosed by the RPE (; ). Long RPE apical processes interdigitate the OS, providing mechanical support and assisting with OS phagocytosis. OS regeneration and phagocytosis are precisely coordinated between the RPE and photoreceptors and under circadian control. Phagocytosed OS fuse with endocytic organelles in the RPE for recycling of essential material to the photoreceptor prior to lysosomal delivery for degradation. OS are packed with membranous disks and their daily phagocytosis places a huge metabolic burden on the RPE. With age, autofluorescent granules derived from poorly digested OS become deposited as lipofuscin, accumulation of which is associated with retinal degeneration (; ).

The RPE also plays an important role in the visual cycle. In response to light, opsin-bound 11-cis-retinal in photoreceptors becomes isomerised to all-trans retinal, activating opsin and triggering phototransduction. However, all-trans-retinol needs to be re-isomerised to 11-cis-retinal in the RPE, to ensure the continuous availability of 11-cis retinal and photoreceptor excitability (; ).

The RPE delivers nutrients and ions from the blood to the neuroretina and electrolytes, water and waste products from the subretinal space to the choroid and regulates the ion composition of the subretinal space to maintain photoreceptor excitability (; ). The RPE secretes neuroprotective growth factors like pigment epithelial growth factor (PEDF) (). Basal secretion of low amounts of vascular endothelial growth factor (VEGF) prevents choroidal endothelial cell apoptosis (; ).

Melanosomes provide photoprotection to both skin and eyes by absorbing light and UV-radiation and scavenging free radicals and reactive oxygen species (; ). In the RPE melanosomes also absorb light scatter. Light energy passing through the photoreceptors is captured by apical RPE melanosomes, with melanosome distribution regulated, at least in part, by the light cycle.

A failure of any of the above RPE functions can result in photoreceptor degeneration, retinal dysfunction and concomitant visual loss.

2 Melanosomes of the RPE

2.1 Melanosome biogenesis

Melanosomes are lysosome-related organelles derived from the endocytic pathway. Studies in skin melanocytes have identified a series of melanosome maturation stages (I–IV) (; ). Striated amyloid fibril formation is initiated by sorting of the transmembrane premelanosome protein (PMEL) onto intraluminal vesicles of multivesicular endosomes (Stage I) where it is cleaved to form fibrils organized into arrays of parallel sheets, giving melanosomes their ellipsoidal shape (stage II). Delivery of melanin-synthesizing enzymes to the immature melanosome initiates melanin deposition onto the fibrils (Stage III) which are obscured by melanin pigment in mature, Stage IV melanosomes. Although low levels of melanin synthesis may occur in adult RPE (), melanosome biogenesis in the RPE is predominantly prenatal, when it proceeds through the same morphologically identifiable stages (I-IV) as in the skin (). By day 36 of human embryonic development, the RPE has developed its characteristic pigmentation () and these melanosomes are retained in the RPE throughout life in contrast to continuous melanosome biogenesis in melanocytes. Melanosome biogenesis is subject to regulation by microphthalmia-associated transcription factor (MITF), a key transcription factor for expression of melanogenic enzymes (). Another transcription factor, Myelin regulatory factor (Myrf), has also recently been implicated in regulating melanosome biogenesis, as well as RPE development (), but to the best of our knowledge, the mechanism for switching off melanosome biogenesis as RPE develop remains elusive. Notably, in vitro RPE cell culture models have been published to study melanosome biogenesis, including murine retinal stem cell–derived (), and human fetal RPE (). These, along with disease-specific iPSC-derived RPE (e.g., OCA1A and 2) (), iron-stimulated ARPE19 cells () and sericin-treated primary human RPE () have demonstrated distinct stages of melanosome maturation (I–IV), making them possible systems for studying melanogenesis in the RPE.

2.2 Albinism and visual function

Melanin is derived from tyrosinase-mediated oxidation of tyrosine, which, in the presence of cysteine gives rise to pheomelanin (yellow-red) or through tyrosinase-related proteins 1 and 2 to eumelanin (brown-black). Loss of function of melanin synthesizing enzymes results in oculocutaneous albinism (OCA), characterized in the eye by foveal hypoplasia, photophobia, nystagmus, reduction in uncrossed retinal projections and reduced visual acuity (; ) (Table 1). The same characteristics are shared by disorders caused by defective melanosome biogenesis, which are also characterized by functional defects in other lysosome-related organelles, such as platelet dense granules and lytic granules of cytotoxic T lymphocytes (Table 1). Paradoxically, the developmental visual defects result from alterations in neurons that do not produce melanin. A bi-product of melanin synthesis, L-DOPA, is a ligand for GPR143 (OA1) (), a heterotrimeric G protein-coupled receptor, mutations in which are responsible of ocular albinism type-1, which is characterized at the cellular level by a reduced number of enlarged melanosomes (). GPR143 signaling within the RPE regulates melanosome motility, interactions with mitochondria, endosome:lysosome fusion, exosome release and secretion of VEGF and PEDGF (; ; ; ). Effects on exosome and cytokine secretion provide a possible explanation of the developmental defects in neurons in ocular albinism.

TABLE 1

Name of disorderDisorder characteristicsGene nameGene function and disease impact on RPE melanosomesReferences OMIM
Oculocutaneous Albinism Type 1Hypopigmentation of the skin, hair and eyes; decreased visual acuity and nystagmusTYRTyrosinase, rate-limiting enzyme for melanin synthesis
→ total loss of RPE melanosomes

#606933
Usher Syndrome 1BProgressive retinal degeneration, profound deafness and vestibular defectsMYO7AMyosin7a, actin motor that regulates melanosome motility
→ lack of melanosomes in apical processes and abnormal phagocytosis

#276900
Griscelli Syndrome type 2Pigmentary dilution of the skin and hair, accumulation of melanosomes in melanocytes and severe haemophagocytic syndromeRAB27aRab27a, Rab GTPase that regulates melanosome distribution
→lack of melanosomes in apical processes

#607624
Ocular Albinism type 1 (also known as X-linked Ocular Albinism)Severe developmental ocular defects, including foveal hypoplasia and misrouting of the optic tracts at the chiasm, decreased visual acuity, nystagmus, photophobia and loss of stereoscopic visionGPR143GPR143 (OA1), G protein coupled receptor that regulates melanosome biogenesis and motility
→reduced number of abnormally large melanosomes

#300500
Donnai-Barrow SyndromeHigh-grade myopia, large protruding eyes, retinal dystrophy, retinal detachmentLRP2Megalin which regulates the endocytic machinery
→abnormally shaped macromelanosomes

# 222448
Chediak-Higashi SyndromeHypopigmentation or oculocutaneous albinism with low vision, nystagmus, and photophobia, and severe immunologic deficiency with neutropeniaLYSTLYST that regulates lysosomal trafficking and autophagosome formation
→abnormal enlarged lysosomes and melanosomes

#214500
Hermansky-Pudlak Syndrome 7 (HPS-7)Oculocutaneous albinism, prolonged bleeding (abnormalities in platelet aggregation), pulmonary fibrosisDTNBP1Dysbindin, component of Biogenesis of Lysosomal Organelle Complex 1 (BLOC-1)
→reduced number of irregularly shaped and small RPE melanosomes

# 614076

Examples of genetic pigmentation disorders in the RPE.

2.3 Melanosome positioning in the RPE

Melanosome transport to the melanocyte periphery for release from dendrites and subsequent uptake into keratinocytes is key for the photoprotective role of melanin in the skin. Similarly, melanosome transport into apical processes of the RPE may offer photoprotection to the retina. RPE cells, like melanocytes, use motor proteins to transport melanosomes along polar microtubules to the cell periphery, but the microtubular organization in RPE cells differs from that in melanocytes. Whereas the microtubule-organizing centre (MTOC), that anchors microtubule minus-ends, is perinuclear in melanocytes, RPE cells have more apically positioned MTOCs (). Melanosomes transported along microtubules to the apical surface of mammalian RPE cells are transferred from microtubule motors to the actin motor protein Myosin VIIa (Myosin Va in melanocytes) for tethering to the actin cytoskeleton (Figure 1B) (). This process, known as cooperative capture, involves tripartite protein complexes that link Myosin VIIa to Rab27a, a small GTPase on the melanosome surface, via the Rab27a effector MyRIP/Slac2-c (Mlph/Slac2-a in melanocytes) (; ; ). In RPE cells from Rab27a-defective ashen and Myosin VIIa-mutant shaker-1 mice, melanosome transport along microtubules was rapid and bidirectional, and melanosomes failed to sequester in the apical region, while disrupting microtubule polymerisation with nocodazole blocked melanosome movement altogether, demonstrating the essential role of microtubule-dependent transport in melanosome positioning (; ).

Bidirectional melanosome transport along microtubules is achieved by recruitment of specific motor proteins, with retrograde minus-end directed transport mediated by dynein motors and anterograde plus-end directed transport towards by kinesin motors (). Due to the difference in polarity, dynein-dependent transport delivers mature melanosomes to the actin-rich apical domain of RPE cells (Figure 1B), but promotes perinuclear positioning in melanocytes (). The essential role of kinesin-dependent transport to the melanocyte periphery has been challenged, with actin-based melanosome transport through Rab27a interaction with actin nucleator SPIRE1 found to mediate peripheral melanosome positioning in melanocytes (). In contrast, in RPE cells dynein-dependent transport along microtubules is required to deliver melanosomes to the actin-rich apical region ().

2.4 Melanosome positioning defects in disease

Melanosome mislocalisation has been reported in human disease (Table 1). Griscelli syndrome (GS) is a rare autosomal recessive disorder, with the most common form, GS2, caused by RAB27A gene mutations, resulting in impaired melanosome transport to the apical processes of the RPE (). However, in addition to its role in melanosome positioning, Rab27a is important for cytotoxic T-lymphocyte granule release, thus as well as albinism, GS2 patients develop immunodeficiency which can result in severe T-cell and macrophage activation and a much reduced life expectancy ().

Loss of Rab27a function is also associated with the rare inherited disease choroideraemia. Characterised by progressive vision loss, choroideraemia is caused by defective Rab Escort Protein 1 (REP1) which is involved in Rab GTPase prenylation, a post-translational modification required for Rab protein function (). In RPE lacking functional REP1, melanosome transport into the apical processes is impaired, but since degradation of photoreceptor OS is also impaired, the contribution of melanosome mislocalisation to disease pathogenesis and vision loss is not clear ().

Similarly in Usher syndrome 1B, melanosome localisation at the apical region of the RPE is defective due to mutations in the MYO-7A gene, but the significance of melanosome mislocalisation to disease pathology is again unclear since myosin-VIIa also participates in delivery of phagocytosed OS in the RPE for lysosomal degradation (). Myosin-VIIa plays additional important roles in the sensory cilia of the inner ear and Usher Syndrome 1B patients are typically profoundly deaf at birth, with progressive retinal degeneration ().

2.5 Melanosome membrane contact sites (MCS)

Melanosomes are derived from endosomes which, like melanosomes, are transported along microtubules. The loading of microtubule motors onto endosomes is strongly influenced by endosome interaction with the ER at membrane contact sites (MCS), where neighbouring organelles are tethered in close apposition (typically 5–40 nm apart). ER:endosome MCS can both promote kinesin-loading for microtubule plus-end directed endosome movement and prevent dynein interaction with endosomal RILP, an effector protein of endosomal Rab7, thereby reducing minus-end directed movement towards the MTOC (). We recently identified extensive ER:melanosome MCS in RPE cells (), but their role in melanosome positioning is yet to be established. Interestingly the ER forms MCS with melanosome of all stages (I-IV) in melanocytes, suggesting additional roles in melanosome maturation (), perhaps orchestrating coordination of maturation with traffic to the periphery for secretion from the dendrites ().

Melanosomes also form MCS with mitochondria, which, in melanocytes, regulate melanosome biogenesis, likely through ATP provision (). Melanosome biogenesis occurs in the perinuclear region of melanocytes, where mitochondrial MCS were found to be most abundant and is stimulated by GPR143, which also promotes melanosome:mitochondria MCS. The mitochondrial protein mitofusin-2 is involved in tethering to melanosomes and required for the stimulation of melanosome biogenesis by GPR143. Melanosomes also form MCS with mitochondria in mature RPE (Figures 1C,D) (; ), suggesting additional functions, possibly in scavenging mitochondrial ROS (), or in Ca2+ flux between the two organelles as has been shown for mitochondria:lysosome MCS () and implicated in melanosome acidification (). Tripartite ER:melanosome:mitochondria MCS found in the RPE may further facilitate buffering of cytosolic Ca2+ and quenching of ROS ().

3 RPE melanosomes in ageing and retinal degeneration

3.1 Age-related changes in RPE melanosomes

Unlike melanosomes of the skin, RPE melanosomes are long-lived. Ageing is, however, accompanied by reduced melanosome numbers and total melanin within the RPE (; ). The melanin becomes more irregularly shaped and less compact and in individuals over 90 years of age virtually all melanosomes are surrounded by other material, including lipofuscin (). Formation of melanolipofuscin, an ill-defined complex, could contribute to the reduced melanosome numbers in the RPE, but does not explain the reduction in total melanin. Melanin polymer is resistant to enzymatic degradation but exposure to intense light, ultraviolet light or oxidising agents can induce RPE melanin degradation (; ). The high levels of light or UV light required to degrade melanin would be unlikely to be encountered by the RPE in vivo but large amounts of superoxides and other reactive oxygen species (ROS) can be produced by lipofuscin-containing granules on light exposure. Direct contact between melanin and lipofuscin within melanolipofuscin granules thus creates conditions favourable for melanin degradation. This leads to a reduction in light absorbance, and anti-oxidant and anti-radical functions, and an increase in melanin’s photochemical reactivity (; ). Thus, melanin degradation can transform melanin-containing granules from “protective” to “toxic”. The association between melanin and lipofuscin in melanolipofuscin has the potential not only to promote melanin degradation, but also to promote lipofuscin degradation by melanin chemiexcitation (see below).

3.2 Role of melanosomes in limiting lipofuscin accumulation

3.2.1 Lipofuscin accumulation

The RPE has a huge degradative burden over a typical lifespan and lipofuscin accumulation begins at an early age (). Lipofuscin accumulates in lysosomes and, indeed, lysosomal delivery of OS was shown to promote the development of autofluorescent lipofuscin-like granules in cultured RPE (). Lipofuscin accumulation can elevate lysosomal pH, inhibiting proteases and lipases, and inhibit cholesterol efflux (; ; ). In the presence of light and oxygen, bisretinoids within lipofuscin can be oxidised forming toxic products that remain in the lipofuscin granule or leak into the cytoplasm causing photo-oxidative stress that can also lead to inflammation and, ultimately, cell death (). Stargardt’s disease caused by loss of function of the lipid flippase, ABCA4 leads to premature and exaggerated accumulation of lipofuscin in the RPE accompanied by degeneration of the neural retina and visual decline (). Lipofuscin accumulation in Stargardt’s disease mouse models is increased on an albino background supporting a role for melanin in limiting lipofuscin accumulation ().

3.2.2 Melanolipofuscin accumulation

The name “Melanolipofuscin” implies that it arises from lipofuscin-containing granules associating/fusing with melanosomes. The presence of autophagy markers and absence of photoreceptor proteins in melanolipofuscin led one study to conclude that melanolipofuscin is formed by melanosome autophagy (). However, intact melanosomes frequently associate with phagosomes (; ) and gold particles labelling OS injected into the subretinal space of rats were subsequently recovered in RPE melanosomes, demonstrating a connection between the phagocytic pathway and melanosomes (). Furthermore, in pigmented mouse models of Stargardt’s disease and Choroideremia, lipofuscin accumulation/defects in phagocytosed OS processing are accompanied by melanolipofuscin accumulation (; ).

3.2.3 Melanin chemiexcitation

A direct role for melanin in limiting lipofuscin production has been indicated by the reversal of excess lipofuscin accumulation in albino Stargardt’s disease mice by virally-induced tyrosinase expression (). Tyrosinase expression, whilst sufficient to induce melanin synthesis, does not induce melanosome formation so the melanin produced likely accumulates in lysosomes with ready access to lipofuscin accumulated within the same organelle. Superoxide generators accelerated lipofuscin degradation but only in the presence of melanin through generation of excited electron states on melanin (melanin chemiexcitation) (). This led to the proposal that OS are partially processed in lysosomes before delivery of lipofuscin to melanosomes for further processing. The trafficking steps and molecular mechanisms required for the meeting of melanin and lipofuscin remain to be elucidated. In ageing RPE irregular shaped melanin is found frequently surrounded by lipofuscin, suggesting fusion between melanosomes and lipofuscin -containing lysosomes. Whether the tethering and SNARE complexes responsible for fusion of lysosomes with other organelles operate in lysosomal fusion with melanosomes remains to be determined, but it is possible that melanosome Ca2+ stores () could contribute to SNARE-dependent fusion events (). The role of autophagy in generation of melanolipofuscin also requires further investigation. Importantly chemi-excitation of melanin results in its destruction, contributing to the age-related loss of ‘functional’ melanin ().

3.3 The relationship between pigmentation and AMD

AMD is the greatest cause of registered blindness in the developed world and is a multifactorial disease with genetic and environmental risk factors, but the greatest risk is age. AMD is characterised by accumulation of lipid-rich deposits basal to the RPE (Drusen) and apical to the RPE (pseudoDrusen). Dry AMD can progress to loss of photoreceptors and RPE cells, known as geographic atrophy, and wet AMD can progress to neovascularisation that compromises Bruchs membrane and the RPE monolayer.

3.3.1 A protective role for RPE melanin in AMD?

As described above, melanin can limit lipofuscin accumulation in the RPE. Interestingly, the accumulation of melanolipofuscin more closely reflects the age of onset of AMD than lipofuscin alone (). Caucasians are significantly more susceptible to AMD than those of African descent (; ; ). A protective role for melanin in AMD would predict that albinism would be linked with a high AMD risk. This has not to our knowledge been reported but could be because albinism is relatively rare and sufferers have a low visual acuity from an early age potentially hindering recognition of AMD. Genome-wide association studies have identified gene variants associated with AMD risk, including complement pathway, extracellular matrix and lipid metabolism genes, the latter including apolipoprotein E (APO-E) (; ). APO-E is required for sorting and processing of PMEL within immature melanosomes and the resulting generation of striations on which melanin is deposited () but whether APO-E gene variants carrying AMD risk are compromised in this function is unclear. Human patients and animal models with lysosomal storage diseases caused by loss of function of specific lysosomal components frequently exhibit AMD-like features. For example, mutation of the lysosomal protease, cathepsin D, causes an aggressive form of the neurodegenerative Batten’s disease and Cathepsin D mutant mice accumulate autofluorescent material in the RPE as well as extracellular basal deposits (). In Danon disease, caused by loss of function of the lysosomal membrane protein LAMP2, autofluorescent material accumulates in the RPE, accompanied by basal deposits and eventual photoreceptor and RPE loss (). A systematic investigation of the effects of defects in melanosome biogenesis or movement on the phenotype of lysosomal storage disease models would help to elucidate the role of melanosomes in the development of AMD features.

3.3.2 GPR143 and AMD

The GPR143 ligand, L-DOPA, is produced during melanin synthesis and Parkinson’s disease patients taking L-DOPA showed reduced/delayed onset of AMD (), suggesting that signalling from GPR143 might protect from AMD. Elevated GPR143 signalling enhances PEGF secretion and suppresses VEGF secretion which could contribute to the protective effect of L-DOPA on risk of geographic atrophy and neovascularisation (). It has also been proposed that signalling from GPR143 could be key to the potential protective effect of melanin on AMD (). Given that most melanin synthesis is prenatal in the RPE, the source of L-DOPA in ageing RPE is not clear and may not be related to melanosomes per se.

3.3.3 Melanin transfer to mononuclear phagocytes in AMD

The appearance of hyperreflective foci in spectral domain optical coherence tomography (SD-OCT) images can predict progression to late stage AMD (; ). Although originally thought to be floating RPE cells they were recently shown to be mononuclear phagophores containing melanin (), raising the question of how they acquired melanin when RPE cells do not normally secrete it. One possibility could be phagocytosis of dying RPE cells. Interestingly CD147 knockout mice have more hyperreflective foci, and reduced RPE pigmentation without RPE cell loss. The authors propose that CD147 acts as a “do not eat me” signal on the RPE that when lost results in phagocytosis of melanosome-containing RPE apical processes that contain melanosomes (). The trafficking events leading to melanin transfer from RPE cells to phagophore remain to be elucidated and, as with the transfer of melanin from skin melanocytes to keratinocytes, more than one mechanism is possible. In skin the predominant mechanism is melanosome fusion with the plasma membrane and melanin secretion (; ). CD147 levels on the RPE decline with age and AMD, and so loss of melanin to MPs could contribute to the age-related decline in RPE pigmentation and increased risk of AMD progression.

4 Perspective

Their long-lived nature and lifelong exposure to photo-oxidative stress distinguishes melanosomes of the RPE from those of skin melanocytes and raises questions about their roles in RPE-specific functions and retinal degenerative disease. What regulates melanosome:phagosome interactions and what is their role in processing phagocytosed OS and generating melanolipofuscin? What is the role of age-related changes in melanin in retinal degenerative diseases like AMD? What is the function of the numerous membrane contacts between melanosomes and other organelles in the RPE and how are they regulated? Increased understanding of melanosome function may pave the way for novel melanosome-targeted therapeutic approaches to the many diseases associated with melanosome misregulation.

Statements

Author contributions

DD: Writing – original draft, Writing – review and editing. EE: Funding acquisition, Writing – original draft, Writing – review and editing. CF: Writing – review and editing, Writing – original draft.

Funding

The author(s) declare that financial support was received for the research and/or publication of this article. This work was generously supported by the Wellcome Trust (grant number 212216/z/18/z awarded to Clare Futter) Moorfields Eye Charity (grant number GR001506, awarded to Dilyana Doncheva and Emily Eden) and Medical Research Council (grant number MR/V013882/1 awarded to Emily Eden).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declare that no Generative AI was used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

Summary

Keywords

retinal pigment epithelium, melanosome, albinism, age-related macular degeneration, melanolipofuscin

Citation

Doncheva D, Eden ER and Futter CE (2025) Specialised features of melanosomes in health and disease in the retinal pigment epithelium. Front. Cell Dev. Biol. 13:1593840. doi: 10.3389/fcell.2025.1593840

Received

14 March 2025

Accepted

08 August 2025

Published

03 September 2025

Volume

13 - 2025

Edited by

Subba Rao Gangi Setty, Indian Institute of Science (IISc), India

Reviewed by

Ruchi Sharma, National Eye Institute (NIH), United States

Updates

Copyright

*Correspondence: Clare E. Futter,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics